Diagnostic potential of oxidative stress markers in children and adolescents with type 1 diabetes

被引：24

作者：

Krzystek-Korpacka, Malgorzata ^{[1
]}

Salmonowicz, Barbara ^{[2
]}

Boehm, Dorota ^{[1
]}

Berdowska, Izabela ^{[1
]}

Zielinski, Bogdan ^{[1
]}

Patryn, Eliza ^{[2
,3
]}

Noczynska, Anna ^{[2
]}

Gamian, Andrzej ^{[1
,4
]}

机构：

[1] Wroclaw Med Univ, Dept Med Biochem, PL-50368 Wroclaw, Poland

[2] Wroclaw Med Univ, Dept Endocrinol & Diabetol Children & Adolescents, Wroclaw, Poland

[3] Wroclaw Med Univ, Dept Ophthalmol, Wroclaw, Poland

[4] Polish Acad Sci, Inst Immunol & Expt Therapy, Wroclaw, Poland

来源：

CLINICAL BIOCHEMISTRY | 2008年 / 41卷 / 1-2期

关键词：

type 1 diabetes mellitus; oxidative stress; AOPP; TBARS; TAS;

D O I：

10.1016/j.clinbiochem.2007.10.003

中图分类号：

R446 [实验室诊断]; R-33 [实验医学、医学实验];

学科分类号：

1001 ;

摘要：

Objectives: To validate the diagnostic utility of oxidative stress markers in the evaluation of young type 1 diabetics, as suggested elsewhere. Design: Advanced oxidation protein products (AOPP), thiobarbituric acid-reactive substances (TBARS) and total antioxidant status (TAS) were measured in sera from diabetics, their siblings and controls, with diagnostic potential evaluated by ROC analysis, and related to diabetes clinical parameters. Results: In diabetics AOPP and TBARS were elevated, TAS decreased. Similar alterations were observed for AOPP and TAS in their siblings. AOPP and TAS were good indicators of diabetes. AOPP and TBARS correlated with HbA(1c) (independent predictor), but were poor markers of non-adequate glycemic control. The cardiovascular disease risk factors were independent predictors of TBARS concentrations. Conclusions: AOPP accumulation and TAS reduction seem to precede diabetes and might be considered as susceptibility indicators in relatives, but not as diabetes markers in general population (no diabetes specificity has been shown). Application in monitoring of metabolic control is not validated. (c) 2007 The Canadian Society of Clinical Chemists. Published by Elsevier Inc. All rights reserved.

引用

页码：48 / 55

页数：8

共 32 条

[1] Lipoprotein oxidation products and arteriosclerosis: Theory and methods with applicability to the clinical chemistry laboratory [J].

Abudu, N ;

Miller, JJ ;

Levinson, SS .

ADVANCES IN CLINICAL CHEMISTRY, VOL. 38, 2004, 38 :1-35

[2] Protein oxidation in obesity and insulin resistance [J].

Atabek, M. Emre ;

Keskin, Mehmet ;

Yazici, Cevat ;

Kendirci, Mustafa ;

Hatipoglu, Nihal ;

Koklu, Esat ;

Kurtoglu, Selim .

EUROPEAN JOURNAL OF PEDIATRICS, 2006, 165 (11) :753-756

[3] Investigation of protein oxidation and lipid peroxidation in patients with rheumatoid arthritis [J].

Baskol, Gulden ;

Demir, Huseyin ;

Baskol, Mevlut ;

Kilic, Eser ;

Ates, Filiz ;

Karakukcu, Cigdem ;

Ustdal, Muzaffer .

CELL BIOCHEMISTRY AND FUNCTION, 2006, 24 (04) :307-311

[4] Further evidence of inflammation in chronic rheumatic valve disease (CRVD): High levels of advanced oxidation protein products (AOPP) and high sensitive C-reactive protein (hs-CRP) [J].

Chiu-Braga, Y. Y. ;

Hayashi, S. Y. ;

Schafranski, M. ;

Messias-Reason, I. J. T. .

INTERNATIONAL JOURNAL OF CARDIOLOGY, 2006, 109 (02) :275-276

[5] Biomarkers of oxidative damage in human disease [J].

Dalle-Donne, I ;

Rossi, R ;

Colombo, R ;

Giustarini, D ;

Milzani, A .

CLINICAL CHEMISTRY, 2006, 52 (04) :601-623

[6] Glycemic control, oxidative stress, and lipid profile in children with type 1 diabetes mellitus [J].

Erciyas, F ;

Taneli, F ;

Arslan, B ;

Uslu, Y .

ARCHIVES OF MEDICAL RESEARCH, 2004, 35 (02) :134-140

[7] Altered redox status in patients with diabetes mellitus type I [J].

Gil-Del Valle, L ;

Milian, LD ;

Toledo, A ;

Vilaró, N ;

Tápanes, R ;

Otero, MA .

PHARMACOLOGICAL RESEARCH, 2005, 51 (04) :375-380

[8]

Gleisner A, 2006, J PEDIATR ENDOCR MET, V19, P995

[9] LDL oxidation is associated with increased blood hemoglobin A1c levels in diabetic patients [J].

Hussein, Osamah A. ;

Gefen, Yacob ;

Zidan, Jamal M. ;

Karochero, Ernest Y. ;

Luder, Anthony S. ;

Assy, Ninier N. ;

Sror, Elyas S. ;

Aviram, Michael Y. .

CLINICA CHIMICA ACTA, 2007, 377 (1-2) :114-118

[10] Advanced glycation end-products and advanced oxidation protein products in patients with diabetes mellitus [J].

Kalousová, M ;

Skrha, J ;

Zima, T .

PHYSIOLOGICAL RESEARCH, 2002, 51 (06) :597-604

← 1 2 3 4 →